ATE23362T1 - Antibiotische verbindung. - Google Patents

Antibiotische verbindung.

Info

Publication number
ATE23362T1
ATE23362T1 AT83100307T AT83100307T ATE23362T1 AT E23362 T1 ATE23362 T1 AT E23362T1 AT 83100307 T AT83100307 T AT 83100307T AT 83100307 T AT83100307 T AT 83100307T AT E23362 T1 ATE23362 T1 AT E23362T1
Authority
AT
Austria
Prior art keywords
threo
proline
acid
sub
hydroxyaspartic
Prior art date
Application number
AT83100307T
Other languages
English (en)
Inventor
Hiroshi Kawaguchi
Masataka Konishi
Koko Sugaward
Koji Tomita
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of ATE23362T1 publication Critical patent/ATE23362T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
AT83100307T 1982-01-15 1983-01-14 Antibiotische verbindung. ATE23362T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/339,355 US4409210A (en) 1982-01-15 1982-01-15 Antibiotic compound
EP83100307A EP0084826B1 (de) 1982-01-15 1983-01-14 Antibiotische Verbindung

Publications (1)

Publication Number Publication Date
ATE23362T1 true ATE23362T1 (de) 1986-11-15

Family

ID=23328637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83100307T ATE23362T1 (de) 1982-01-15 1983-01-14 Antibiotische verbindung.

Country Status (6)

Country Link
US (1) US4409210A (de)
EP (1) EP0084826B1 (de)
JP (1) JPS58140053A (de)
AT (1) ATE23362T1 (de)
CA (1) CA1198695A (de)
DE (1) DE3367413D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0157544A3 (de) * 1984-03-29 1987-08-05 Takeda Chemical Industries, Ltd. Antibiotika, deren Herstellung und Benutzung
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5057493A (en) * 1988-07-19 1991-10-15 Takara Shuzo Co., Ltd. Novel antibiotics r106
US5260214A (en) * 1988-07-19 1993-11-09 Takara Shuzo Co. Aureobasidium pullulans which produces antibiotic R106
JP2863934B2 (ja) * 1989-07-24 1999-03-03 塩野義製薬株式会社 抗生物質プラスバシン
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
AU3837600A (en) * 1999-04-16 2000-11-02 Sankyo Company Limited Novel antifungal compounds
KR100407128B1 (ko) * 2000-10-20 2003-11-28 주식회사 바이오리 송화가루 또는 송화가루 추출물을 함유하는 피부외용제
AU2002232176B2 (en) * 2001-02-19 2006-06-15 Takara Bio Inc. Cyclic peptide
JP2010519301A (ja) * 2007-02-26 2010-06-03 オーレオジェン バイオサイエンシーズ 感染を処置する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508766A1 (fr) * 1981-07-03 1983-01-07 Berri Balzac Nouvelle substance antifongique obtenue a partir d'une souche de bacillus subtilis, son procede d'obtention et ses applications comme antifongique

Also Published As

Publication number Publication date
JPS58140053A (ja) 1983-08-19
DE3367413D1 (en) 1986-12-11
US4409210A (en) 1983-10-11
EP0084826A2 (de) 1983-08-03
EP0084826B1 (de) 1986-11-05
EP0084826A3 (en) 1983-09-21
CA1198695A (en) 1985-12-31
JPH0329080B2 (de) 1991-04-23

Similar Documents

Publication Publication Date Title
KR880004097A (ko) 글리코펩티드 항생물질
BG60053B2 (bg) Метод за повишаване способността за получаване на антибиотик
BG48922A3 (en) Method for preparing nutritive composition for animals
ATE23362T1 (de) Antibiotische verbindung.
HUP9801420A2 (hu) Eljárás L-aminosavak előállítására fermentálással
KR960700346A (ko) 면역억제제의 제조방법 및 이에 사용되는 신규 미생물(a process for producing immunosuppressives and a novel microbial species to be employed therein)
ES8705893A1 (es) Un procedimiento para preparar derivados monoamidicos basicos de actagardina
DK457585A (da) Fremgangsmaade til fremstilling af derivater af det antibiotisk virksomme cycliske peptid a-21978 c
ES2002731A6 (es) Un metodo de preparacion de nuevos antibioticos peptidicos y su empleo como agentes antimicrobianos y antitumorales.
MY113838A (en) Process for production of amide compounds using microorganism
EP0337731A3 (de) Peptid-Antibiotika
EP0438600A4 (en) Enzymes which participate in c-terminal amidation, and production and use thereof
GB1500965A (en) Cyclic ether antibiotics
JPS57171925A (en) Antibiotic compound
GB1530921A (en) Desacylpepsidine and the preparation thereof
MX9709494A (es) Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
ATE20604T1 (de) Erythromycin d und dessen ester durch fermentation.
DE69517761D1 (de) Neues aus einem marinen actionmyceten isoliertes thiodepsipeptid
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
JPS557015A (en) Proline acylase, its preparation and preparation of l-proline
SU1135754A1 (ru) Способ восстановлени серологически атипичных штаммов микроорганизмов в @ -форму
IE45014L (en) Antibiotic a-7413.
Kimura et al. Prohisin, new thiol protease inhibitor produced by Cephalosporium sp. KM 388
GB1388198A (en) Antibiotic fr-1923 and a process for the preparation thereof
JPS6455149A (en) Feed

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee